← All trials
NCT02972957
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2017
- Primary completion
- Jan 1, 2019
- Completion date
- Dec 1, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 365
- Arms / groups
- 4 / —
- Source
- AACT · pre-existing
Sponsors
- Medical Research Council, The GambiaLead sponsor
- University of EdinburghCollaborator
- Public Health EnglandCollaborator
- University of OxfordCollaborator
- National Institute for Public Health and the Environment, RIVM, HollandCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.